dexmedetomidine has been researched along with Cardiac Diseases in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ellepola, CD; Frommelt, M; Frommelt, PC; Handler, SS; Hoffman, G; Saudek, DE; Scott, J | 1 |
| Gao, M; Liu, D; Liu, Y; Song, F; Yang, P; Yu, T; Zhang, M; Zhang, X | 1 |
| Jin, X; Li, Z; Pan, D; Shen, R; Wang, H; Wang, Z | 1 |
| Bartz, P; Frommelt, PC; Lavoie, J; Saudek, DE; Schaal, A; Shreve, S; Walbergh, D | 1 |
| Jin, S; Zhou, X | 1 |
| Ling, X; Ni, Y; Wu, C; Zhang, C; Zhou, H; Zhu, Z | 1 |
| Beattie, WS; Duncan, D; Sankar, A; Wijeysundera, DN | 1 |
| Ao, H; Chen, S; Ma, J; Wang, Q; Xu, F | 1 |
| Ling, XY; Ni, YJ; Wu, C; Zhou, HM; Zhu, ZP | 1 |
| Fleming, N; Ji, F; Li, Z; Liu, H; Nguyen, H; Shi, P; Young, N | 1 |
| Burns, J; Finkel, JC; Jackson, K; Quezado, ZM; Sheehy, KA | 1 |
| Diaz, LK; Jones, L | 1 |
| Beattie, WS; Bender, JS; Wijeysundera, DN | 1 |
| Callahan, PM; Chrysostomou, C; Haney, J; Jooste, EH; Lichtenstein, SE; Morell, VO; Munoz, R; O'Malley, E; Orr, R; Sanchez-de-Toledo, J; Shiderly, D; Suresh, T; Wearden, P; Yoshida, M | 1 |
| Berry, DE; Burbano, NH; Munoz, RA; Orr, RA; Otero, AV | 1 |
| Gossett, JM; Gupta, P; Roth, SJ; Sabati, A; Tesoro, TM; Tobias, JD; Whiteside, W | 1 |
| Hall, SR; Hong, M; Milne, B; Wang, L | 1 |
| Aantaa, R; Jalonen, J | 1 |
5 review(s) available for dexmedetomidine and Cardiac Diseases
| Article | Year |
|---|---|
Influence of dexmedetomidine on cardiac complications in non-cardiac surgery: a meta-analysis of randomized trials.
Topics: Adrenergic alpha-2 Receptor Agonists; Bradycardia; Dexmedetomidine; Heart Diseases; Humans; Hypotension; Mortality; Postoperative Complications; Randomized Controlled Trials as Topic | 2017 |
Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Coronary Artery Bypass; Databases, Factual; Dexmedetomidine; Heart Diseases; Humans; Intensive Care Units; Odds Ratio; Propofol; Randomized Controlled Trials as Topic; Risk Factors; Tachycardia | 2018 |
Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery.
Topics: Adrenergic alpha-Agonists; Clonidine; Dexmedetomidine; Heart Diseases; Humans; Imidazoles; Intraoperative Complications; Myocardial Infarction; Postoperative Complications; Randomized Controlled Trials as Topic; Stress, Physiological; Stroke; Surgical Procedures, Operative | 2018 |
Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery.
Topics: Adrenergic alpha-Agonists; Clonidine; Dexmedetomidine; Heart Diseases; Humans; Imidazoles; Intraoperative Complications; Postoperative Complications; Randomized Controlled Trials as Topic; Stress, Physiological; Surgical Procedures, Operative | 2009 |
Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Cardiovascular Physiological Phenomena; Clonidine; Dexmedetomidine; Heart Diseases; Humans; Perioperative Care | 2006 |
1 trial(s) available for dexmedetomidine and Cardiac Diseases
| Article | Year |
|---|---|
Perioperative dexmedetomidine improves outcomes of cardiac surgery.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Aged; Cardiac Surgical Procedures; Catecholamines; Delirium; Dexmedetomidine; Female; Heart Diseases; Hospital Mortality; Hospital Records; Humans; Hypnotics and Sedatives; Length of Stay; Male; Middle Aged; Myocardial Ischemia; Patient Readmission; Perioperative Care; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Stroke; Treatment Outcome | 2013 |
12 other study(ies) available for dexmedetomidine and Cardiac Diseases
| Article | Year |
|---|---|
Intranasal dexmedetomidine for transthoracic echocardiography in infants with shunt-dependent single ventricle heart disease.
Topics: Dexmedetomidine; Echocardiography; Heart Diseases; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Univentricular Heart | 2023 |
Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line; Cytokines; Dexmedetomidine; Disease Models, Animal; Heart Diseases; Inflammation Mediators; Male; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Wistar; Sepsis; Signal Transduction; Ventricular Function, Left | 2019 |
The Effects of Dexmedetomidine Post-Conditioning on Cardiac and Neurological Outcomes After Cardiac Arrest and Resuscitation in Swine.
Topics: Animals; Brain Diseases; Cardiopulmonary Resuscitation; Dexmedetomidine; Disease Models, Animal; Heart Arrest; Heart Diseases; Male; Random Allocation; Swine; Treatment Outcome | 2021 |
Intranasal dexmedetomidine: the ideal drug for sedation in the pediatric echo lab?
Topics: Child; Chloral Hydrate; Cyanosis; Dexmedetomidine; Heart Diseases; Humans; Hypnotics and Sedatives; Infant; Pediatrics; Pharmaceutical Preparations | 2022 |
The association between intraoperative dexmedetomidine and 1 year morbidity and mortality after cardiac surgery: A propensity matched analysis of over 1400 patients.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Cardiac Surgical Procedures; China; Dexmedetomidine; Female; Heart Diseases; Humans; Intraoperative Care; Male; Middle Aged; Morbidity; Mortality; Odds Ratio; Postoperative Complications; Postoperative Period; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors | 2018 |
Pre-cardiopulmonary bypass administration of dexmedetomidine decreases cardiac troponin I level following cardiac surgery with sevoflurane postconditioning.
Topics: Analgesics, Non-Narcotic; Anesthetics, Inhalation; Cardiopulmonary Bypass; Dexmedetomidine; Female; Follow-Up Studies; Heart Diseases; Humans; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Prognosis; Retrospective Studies; Sevoflurane; Troponin I | 2019 |
The Use of Dexmedetomidine in Pediatric Palliative Care: A Preliminary Study.
Topics: Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Cohort Studies; Dexmedetomidine; Female; Heart Diseases; Humans; Hypnotics and Sedatives; Infant; Male; Pain; Palliative Care | 2017 |
Sedating the child with congenital heart disease.
Topics: Adolescent; Analgesia; Barbiturates; Benzodiazepines; Child; Child, Preschool; Conscious Sedation; Dexmedetomidine; Etomidate; Fentanyl; Heart Diseases; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Monitoring, Intraoperative; Practice Guidelines as Topic; Propofol | 2009 |
Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations.
Topics: Adrenergic alpha-2 Receptor Agonists; Cardiac Surgical Procedures; Dexmedetomidine; Female; Follow-Up Studies; Heart Diseases; Humans; Incidence; Infant; Infant, Newborn; Length of Stay; Male; Perioperative Care; Prospective Studies; Survival Rate; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome; United States | 2011 |
Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.
Topics: Adolescent; Child; Child, Preschool; Critical Illness; Dexmedetomidine; Female; Heart Diseases; Humans; Hypnotics and Sedatives; Infant; Male; Retrospective Studies; Time Factors; Withholding Treatment | 2012 |
Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
Topics: Blood Pressure; Child, Preschool; Critical Care; Critical Illness; Dexmedetomidine; Female; Heart Diseases; Heart Rate; Humans; Hypertension; Hypnotics and Sedatives; Infant; Length of Stay; Male; Midazolam; Morphine; Myocardial Contraction; Narcotics; Oxygen; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Tachycardia; Time Factors | 2012 |
Central dexmedetomidine attenuates cardiac dysfunction in a rodent model of intracranial hypertension.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Catecholamines; Dexmedetomidine; Disease Models, Animal; Electrocardiography; Heart Diseases; Heart Function Tests; Heart Rate; Hemodynamics; Intracranial Hypertension; Male; Malondialdehyde; Norepinephrine; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Function, Left | 2004 |